Lastly, a recent analysis of expression data in schizophrenia and bipolar disorder found unchanged DDAH1/2 mRNA levels in the prefrontal cortex but significant functional shifts, including disrupted coexpression with psychiatric risk genes and reduced integration into shared gene networks, likely due to altered transcription factor activity (159). This evidence concerns the gene DDAH1 and schizophrenia.